Irina V. Bure

1.0k total citations
42 papers, 697 citations indexed

About

Irina V. Bure is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Irina V. Bure has authored 42 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Irina V. Bure's work include Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (8 papers) and Circular RNAs in diseases (6 papers). Irina V. Bure is often cited by papers focused on Cancer-related molecular mechanisms research (11 papers), MicroRNA in disease regulation (8 papers) and Circular RNAs in diseases (6 papers). Irina V. Bure collaborates with scholars based in Russia, Germany and United Kingdom. Irina V. Bure's co-authors include М. В. Немцова, Ekaterina Kuznetsova, Zaletaev Dv, Dmitry S. Mikhaylenko, Ekaterina A. Alekseeva, Andrey A. Zamyatnin, Alexander N. Lukashev, Andrei A. Deviatkin, Evgeny A. Moskalev and Jörg D. Hoheisel and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Irina V. Bure

36 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irina V. Bure Russia 13 411 243 121 98 76 42 697
М. В. Немцова Russia 15 556 1.4× 266 1.1× 183 1.5× 109 1.1× 105 1.4× 93 885
Huey-En Tzeng Taiwan 16 376 0.9× 177 0.7× 183 1.5× 50 0.5× 82 1.1× 29 669
Fujun Zhao China 14 442 1.1× 243 1.0× 97 0.8× 67 0.7× 153 2.0× 38 683
Sarah J. Aitken United Kingdom 10 361 0.9× 302 1.2× 213 1.8× 42 0.4× 100 1.3× 14 785
Enyu Huang China 17 355 0.9× 202 0.8× 109 0.9× 51 0.5× 59 0.8× 27 761
Jeffrey Chen United States 6 384 0.9× 91 0.4× 195 1.6× 71 0.7× 91 1.2× 11 712
Karolina Przybyłowska Poland 17 379 0.9× 303 1.2× 241 2.0× 43 0.4× 52 0.7× 48 828
Tomoyo Yasui Japan 15 263 0.6× 156 0.6× 202 1.7× 37 0.4× 72 0.9× 58 637
Qi Wan China 15 401 1.0× 199 0.8× 118 1.0× 24 0.2× 121 1.6× 58 751
Zhaomei Zhang United States 12 239 0.6× 93 0.4× 100 0.8× 79 0.8× 118 1.6× 13 548

Countries citing papers authored by Irina V. Bure

Since Specialization
Citations

This map shows the geographic impact of Irina V. Bure's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irina V. Bure with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irina V. Bure more than expected).

Fields of papers citing papers by Irina V. Bure

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irina V. Bure. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irina V. Bure. The network helps show where Irina V. Bure may publish in the future.

Co-authorship network of co-authors of Irina V. Bure

This figure shows the co-authorship network connecting the top 25 collaborators of Irina V. Bure. A scholar is included among the top collaborators of Irina V. Bure based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irina V. Bure. Irina V. Bure is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bure, Irina V., et al.. (2025). Potential Regulation of ARID1A by miR-129-5p and miR-3613-3p and Their Prognostic Value in Gastric Cancer. International Journal of Molecular Sciences. 26(1). 305–305. 3 indexed citations
2.
3.
Belenkov, Yu. N., et al.. (2023). MiRNA-21a, miRNA-145, and miRNA-221 Expression and Their Correlations with WNT Proteins in Patients with Obstructive and Non-Obstructive Coronary Artery Disease. International Journal of Molecular Sciences. 24(24). 17613–17613. 4 indexed citations
4.
Bure, Irina V., et al.. (2023). Genetic markers associated with adverse reactions of radioiodine therapy in thyroid cancer patients. Drug Metabolism and Personalized Therapy.
5.
Bure, Irina V., et al.. (2023). Genetic markers associated with adverse reactions of radioiodine therapy in thyroid cancer patients. Drug Metabolism and Personalized Therapy. 38(3). 255–265. 1 indexed citations
6.
Немцова, М. В. & Irina V. Bure. (2023). Targeting of the SWI/SNF chromatin remodeling complex in cancer therapy. SHILAP Revista de lepidopterología. 10(1). 8–17.
7.
Bure, Irina V., et al.. (2022). Genetic markers associated with resistance to radioiodine therapy in thyroid cancer patients: Prospective cohort study. SHILAP Revista de lepidopterología. 24(3). 345–350. 2 indexed citations
8.
9.
Mikhaylenko, Dmitry S., Ekaterina Kuznetsova, Irina V. Bure, et al.. (2022). Genetic and Clinical Factors Associated with Olokizumab Treatment in Russian Patients with Rheumatoid Arthritis. Journal of Personalized Medicine. 12(4). 641–641. 3 indexed citations
10.
Bure, Irina V., К. Б. Мирзаев, О. Д. Остроумова, et al.. (2021). MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring. Drug Metabolism and Personalized Therapy. 37(1). 41–46. 3 indexed citations
11.
Alekseeva, Ekaterina A., Tatiana L. Ushakova, T. P. Kazubskaya, et al.. (2021). Parental Origin of the RB1 Gene Mutations in Families with Low Penetrance Hereditary Retinoblastoma. Cancers. 13(20). 5068–5068. 6 indexed citations
12.
Немцова, М. В., Ekaterina Kuznetsova, Irina V. Bure, et al.. (2021). Mutations in Epigenetic Regulation Genes in Gastric Cancer. Cancers. 13(18). 4586–4586. 9 indexed citations
13.
Mikhaylenko, Dmitry S., Ekaterina Kuznetsova, M. Yu. Martynov, et al.. (2021). <i>FGFR3, TERT, ТР53</i> mutations and the <i>FGFR3</i> gene expression in bladder cancer as prognostic markers. SHILAP Revista de lepidopterología. 17(1). 89–100.
14.
Bure, Irina V., К. Б. Мирзаев, О. Д. Остроумова, et al.. (2021). MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring. Drug Metabolism and Personalized Therapy. 0(0). 1 indexed citations
15.
Немцова, М. В., Ekaterina Kuznetsova, Irina V. Bure, et al.. (2020). Clinical relevance of somatic mutations in main driver genes detected in gastric cancer patients by next-generation DNA sequencing. Scientific Reports. 10(1). 504–504. 33 indexed citations
16.
Сычев, Д. А., et al.. (2019). Clinical pharmacology technologies for personalization of cardiovascular diseases drug treatment: focus on direct oral anticoagulants. Annals of the Russian academy of medical sciences. 74(5). 299–306. 1 indexed citations
17.
Bure, Irina V., Jasmin Knopf, Philipp Ströbel, et al.. (2018). Long noncoding RNA HOTAIR is upregulated in an aggressive subgroup of gastrointestinal stromal tumors (GIST) and mediates the establishment of gene‐specific DNA methylation patterns. Genes Chromosomes and Cancer. 57(11). 584–597. 18 indexed citations
18.
Bure, Irina V., Ekaterina Kuznetsova, & Zaletaev Dv. (2018). Длинные некодирующие РНК и их роль в онкогенезе. Молекулярная биология. 52(6). 907–920. 11 indexed citations
19.
Bure, Irina V., Florian Haller, & Zaletaev Dv. (2018). Coding and Non-coding: Molecular Portrait of GIST and its Clinical Implication. Current Molecular Medicine. 18(4). 252–259. 5 indexed citations
20.
Bure, Irina V., Alexander Braun, Helene Geddert, et al.. (2017). The expression of hematopoietic progenitor cell antigen CD34 is regulated by DNA methylation in a site‐dependent manner in gastrointestinal stromal tumours. International Journal of Cancer. 141(11). 2296–2304. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by М. В. Немцова Breakdown of academic impact, for papers by Huey-En Tzeng Breakdown of academic impact, for papers by Fujun Zhao Breakdown of academic impact, for papers by Sarah J. Aitken Breakdown of academic impact, for papers by Enyu Huang Breakdown of academic impact, for papers by Jeffrey Chen Breakdown of academic impact, for papers by Karolina Przybyłowska Breakdown of academic impact, for papers by Tomoyo Yasui Breakdown of academic impact, for papers by Qi Wan Breakdown of academic impact, for papers by Zhaomei Zhang
Rankless by CCL
2026